Navigation Links
Neurocrine Biosciences Announces Notice of Allowance for Composition of Matter Patent on VMAT2 Inhibitor
Date:6/23/2011

ng minimal impact on the other monoamines thereby reducing the likelihood of "off target" side effects.NBI-98854 is designed to provide low, sustained, plasma and brain concentrations of active drug to minimize side effects associated with excessive dopamine depletion.

NBI-98854 may be useful in other disorders such as Huntington's chorea, schizophrenia, Tourette's syndrome, and tardive dystonia.

About Neurocrine Biosciences

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.

In addition to historical facts, this press release may contain forward-looking statements that involve a number of risks and uncertainties. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with Neurocrine's business and finances in general, as well as risks and uncertainties associated with the Company's VMAT2 program and Company overall. Specifically, the risks and uncertainties the Company faces with respect to the Company's VMAT2 program include, but are not limited to; risk that NBI-98854 will not proceed to later stage clinical trials and risk that the Company's clinical trials will fail to demonstrate that NBI-98854 is safe and effective. With respect to its pipeline overall, the Company faces risk that it will be unable to raise additional funding required to complete development of all of its product candidates; risk relating to the Company's dependence on contra
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Neurocrine Biosciences Announces Successful Phase IIa Clinical Trial for VMAT2 Inhibitor
2. Neurocrine Biosciences to Present at the Cowen & Co. 31st Annual Health Care Conference
3. Neurocrine Biosciences Reports Fourth Quarter and Year End 2010 Results
4. Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2010 Financial Results
5. Abbott and Neurocrine Announce Global Agreement to Develop and Commercialize Elagolix for the Treatment of Endometriosis
6. Neurocrine Biosciences Announces Conference Call and Webcast on Worldwide Agreement With Abbott on Elagolix
7. Neurocrine Biosciences to Present at the Jefferies 2010 Global Life Sciences Conference and the 9th Annual Needham Healthcare Conference
8. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2010 Financial Results
9. Neurocrine Biosciences, Inc. Announces Exercise of Over-Allotment Option for Common Stock Offering
10. Neurocrine Biosciences to Present at the Roth 22nd Annual OC Growth Conference
11. Neurocrine Biosciences Announces the Appointment of William H. Rastetter to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of biologics ... announced today that Jeffrey Riley , CEO, ... MicroCap Conference on Thursday, May 30, 2013 in ... Mr. Riley is scheduled to present at 10:00 a.m. (Eastern ... can be accessed by logging onto the web at ...
(Date:5/21/2013)... 21, 2013 Inflamax scientists worked ... ITN to design the study, which will provide ... clinical models used in the study of allergy ... Allergen Challenge (NAC) models. Although both the models ... to date no direct comparison between the allergic ...
(Date:5/21/2013)... MN (PRWEB) May 21, 2013 The ... show display solution for sales and marketing teams looking for ... describes the kit as “everything you’ll need to put ... Fabric Display Kit comes with a number of displays and ... trade booth 20 feet by 20 feet in size. These ...
(Date:5/20/2013)...  MiMedx Group, Inc. (NASDAQ: MDXG ), ... regenerative biomaterials and bioimplants processed from human amniotic membrane, ... of credit with Bank of America.  The revolving line ... accounts receivable and inventory, allows MiMedx to borrow up ... will be used for general corporate purposes. ...
Breaking Biology Technology:Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference 2Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2GLM Displays Announces All-in-One Formulate Fusion Fabric Display Kit 2
... LAFAYETTE, Ind. - Researchers at Purdue University are ... fit inside laptops and personal computers, a cooling ... size of computers. , Unlike conventional cooling systems, ... finned devices called heat sinks attached to computer ...
... JumpStart Inc., the Northeast Ohio,venture development organization ... and ideas, has announced an investment commitment ... JumpStart,investment is part of a recently closed ... Management of Cleveland, OH., (Logo: ...
... to Adipose-Derived Stem Cells; business ... likely affected., SUNNYVALE, Calif., June 19 ... concerning the foundational,composition-of-matter patent covering stem cells isolated ... of Artecel,s licensor, the,University of Pittsburgh (,Pittsburgh,) and ...
Cached Biology Technology:Tiny refrigerator taking shape to cool future computers 2Tiny refrigerator taking shape to cool future computers 3JumpStart Invests in Tursiop Technologies 2JumpStart Invests in Tursiop Technologies 3Court Determines that University of Pittsburgh and Artecel Have Sole Rights to Adipose-Derived Stem Cell Patent 2Court Determines that University of Pittsburgh and Artecel Have Sole Rights to Adipose-Derived Stem Cell Patent 3Court Determines that University of Pittsburgh and Artecel Have Sole Rights to Adipose-Derived Stem Cell Patent 4
(Date:5/21/2013)... battle? Try staying fit in space, where living quarters ... , That,s the challenge a group of Michigan State ... million grant from NASA. Their goal is to keep ... "You could give astronauts the best exercise regimen there ... to it, it isn,t going to help," said project ...
(Date:5/21/2013)... ANDOVER, Mass. , May 21, 2013 ... that CX50 xMATRIX, the world,s first portable ultrasound with ... Intracardiac Echo (ICE) capability. The CX50 xMATRIX with available ... Paris at the EuroPCR, official ... (EAPCI), May 21-24. Since its launch in ...
(Date:5/20/2013)... the lungs of the planet, inhales carbon dioxide as it ... grow parts that eventually fall to the ground to decompose ... , Until recently people believed much of the rain forest,s ... in the ocean. University of Washington research showed a decade ... though left open the question of how that was possible, ...
Breaking Biology News(10 mins):Fueling fitness on the final frontier 2Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2Amazon River exhales virtually all carbon taken up by rain forest 2Amazon River exhales virtually all carbon taken up by rain forest 3
... a potentially patentable method to arrest toxic leakages of ... gene therapy against cancerous tumors. The problem has been ... from tumors, proving toxic to other body tissues. , ... changes from a liquid at 39 degrees Fahrenheit to ...
... The recent discovery of a 90-million-year-old dinosaur in ... theropods that includes Velociraptor and is closely related ... Rather than originating during the Cretaceous, dromaeosaurs can ... as far back as 180 million years ago. ...
... exact chemical blend of a pheromone emitted by older male ... mating and how other surrounding elephants behave, a new study ... Science University and the University of Auckland in New Zealand ... images of the pheromone, frontalin, depends on whether the male ...
Cached Biology News:Polymer gel can block toxic leakage problem in gene therapy 2Polymer gel can block toxic leakage problem in gene therapy 3Polymer gel can block toxic leakage problem in gene therapy 4Newly discovered birdlike dinosaur is oldest raptor ever found in South America 2Newly discovered birdlike dinosaur is oldest raptor ever found in South America 3Newly discovered birdlike dinosaur is oldest raptor ever found in South America 4Male elephants woo females with precise chemistry 2Male elephants woo females with precise chemistry 3
...
Removes polysaccharide and phenolic inhibitors of PCR; yields DNA greater than 50 kb in length...
...
Caspase Activity Detector, SR-VAD-FMK Kit , 100 tests Consult technical datasheet for details....
Biology Products: